NCT01725529
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Beijing, China
- Changchun, China
- Changsha, China
- Chengdu, China
Clinical trial condition
Communicable Diseases
Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.
9,170 public trials
550 recruiting studies
Communicable Diseases trial results
NCT00487188
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Cleveland, Ohio, United States
- Austin, Texas, United States
- Dallas, Texas, United States
- Vancouver, British Columbia, Canada
NCT00932009
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
- Inst. of Cancer Epidemiology, Danish Cancer Society Copenhagen, Denmark
NCT01909778
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
- Locations
-
- 1220.15.49006 Boehringer Ingelheim Investigational Site Mainz, Germany
NCT00977756
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Univ. of Alabama Birmingham NICHD CRS (5096) Birmingham, Alabama, United States
- Miller Children's Hospital Long Beach, CA NICHD CRS (5093) Long Beach, California, United States
- Usc La Nichd Crs (5048) Los Angeles, California, United States
- UCSD Mother, Child & Adolescent HIV Program(4601) San Diego, California, United States
NCT01112033
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Institute of Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague Prague, Czechia
NCT02196064
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
- Locations
-
- Fundación Pública Andaluza Progreso y Salud Seville, Sevilla, Spain
NCT01637922
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
- 1220.57.0001 Boehringer Ingelheim Investigational Site Atlanta, Georgia, United States
- 1220.57.0002 Boehringer Ingelheim Investigational Site Overland Park, Kansas, United States
- 1220.57.0003 Boehringer Ingelheim Investigational Site Salt Lake City, Utah, United States
Completed
Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects
NCT00654147
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- University of Miami AIDS Clinical Research Unit Miami, Florida, United States
NCT01579474
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
- 1220.54.08104 Boehringer Ingelheim Investigational Site Chuo-ku, Chiba, Japan
- 1220.54.08118 Boehringer Ingelheim Investigational Site Chuo-ku, Kobe, Hyogo, Japan
- 1220.54.08108 Boehringer Ingelheim Investigational Site Fukui, Fukui, Japan
- 1220.54.08110 Boehringer Ingelheim Investigational Site Gifu, Gifu, Japan